GUIDE-IN-TMS: MRI guided depression treatment planning for individualized, network-targeted transcranial magnetic stimulation
Description of the granted funding
Major depression disorder is the third leading cause of disability worldwide, and one out of fifteen people in the developed world suffer from it. Unfortunately, half of these people do not respond to antidepressants. There is therefore an urgent need for effective and well-tolerated alternative treatments for depression. One such promising technique is transcranial magnetic stimulation (TMS), which has been used in hospitals for several years. The efficacy of TMS is, however, currently limited. The goal of this project is to develop TMS into a highly effective depression treatment approach. To achieve this, we will make personalized treatment plans using new magnetic resonance imaging techniques, which we will develop in this project. We expect that this project can lead to a breakthrough in depression treatment. In the long term, our approach can serve as a blueprint to develop new personalized TMS treatments for other brain disorders as well.
Show moreStarting year
2022
End year
2027
Granted funding
Related funding decisions
368476
Research costs of Academy Research Fellows(2025)
156 207 €
353798
Research costs of Academy Research Fellows(2022)
240 000 €
Funder
Research Council of Finland
Funding instrument
Academy research fellows
Decision maker
Scientific Council for Natural Sciences and Engineering
12.05.2022
12.05.2022
Other information
Funding decision number
348631
Fields of science
Neurosciences
Research fields
Neurotiede
Identified topics
brain, neuroscience